tirzepatide 80 mg GLP-2 (40mg vials) Alternative dosing regimens of GLP-1

Many patients continue compounded injections or switch to oral formulations ($289 per month) for convenience

Obesity The global incidence of obesity is steadily increasing and is closely linked to various health issues, including type 2 diabetes, atherosclerosis, hypertension, cardiovascular diseases, and cancer

In an announcement of the study on the Vanderbilt website, lead author Khrysta Baig described this as a purely hypothetical scenario, but one that underscores that at current prices, these medications cannot be the only way or even the main way we address obesity as a society. In a more conservative estimate, Bhaig and coauthors consider a case where only about 10% of those eligible for obesity treatment opted for semaglutide, which would result in $27 billion in new costs

That's the point